Thank you to everyone who participated in the Summit topic selection survey. We received 66 responses, providing valuable feedback to help shape the direction of the PET Drug Manufacturing Summit. Following review of the survey results, the Program Committee met and identified several key discussion areas to address during the Summit. Based on participant input, the preliminary program topics and discussion moderators currently include:

1. FDA’s Environmental Monitoring Enforcement
   Discussion moderators: Marianna Dakanali (University of Michigan) and Rick Jahn (GE HealthCare)

2. Incoming Materials Testing
   Discussion moderators: Robin Cumming (UCSF) and Chris Parr (Pharmalogic)

3. Addressing FDA Inconsistency and the Training Level of FDA Reviewers and Inspectors
   Discussion moderators: David Dick (University of Iowa) and Eric Webster (Telix Pharmaceuticals)

4. Communicating Risk Assessment and Justification with the FDA
   Subcommittee members: Cathy S. Cutler (Brookhaven National Labs), Rick Jahn (GE Healthcare), Henry VanBrocklin (UCSF) and Steve Zigler (PETNET)

5. External Relationships: Effective Cultivation & Communication
   Discussion moderators: Adam Rosenberg (Vanderbilt University) and Steve Zigler (PETNET)

6. Theragnostics
   Discussion moderators: Cathy S. Cutler (Brookhaven National Labs) and TBD

These sessions are being designed as collaborative, solutions-oriented discussions focused on identifying practical paths forward for the PET drug manufacturing community. Please note that the program is still in preliminary development and topics, session formats, moderators, and timing remain subject to change as planning continues. Additional program details will be posted as they become available.